Guardant Health (GH) Net Cash Flow (2017 - 2026)

Guardant Health has disclosed Net Cash Flow across 10 years of filings, most recently posting $66.7 million for Q2 2026.

• In Q2 2026, Net Cash Flow rose 196.25% year-over-year to $66.7 million; the TTM figure through Jun 2026 stood at $434.1 million (up 243.89% YoY), while the FY2025 annual figure was -$140.8 million, up 71.96% from the prior year.
• Net Cash Flow came in at $66.7 million for Q2 2026 at Guardant Health, down from $612.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $675.3 million in Q4 2023 to a low of -$356.9 million in Q2 2022.
• Average Net Cash Flow over 5 years is $37.8 million, with a median of -$10.5 million recorded in 2022.
• Year-over-year, Net Cash Flow tumbled 614.42% in 2022 and jumped 5365.04% in 2025.
• Over 5 years, Net Cash Flow stood at -$17.8 million in 2022, then surged by 3892.93% to $675.3 million in 2023, then slumped by 108.43% to -$56.9 million in 2024, then slumped by 250.35% to -$199.4 million in 2025, then soared by 133.45% to $66.7 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $66.7 million in Q2 2026, $612.2 million in Q1 2026, and -$199.4 million in Q4 2025.